These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27091891)

  • 1. There Is Still Room for Improvement: Presentation of a Neutral Borosilicate Glass with Improved Chemical Stability for Parenteral Packaging.
    Boltres B; Tratzky S; Kass C; Eichholz R; Naß P
    PDA J Pharm Sci Technol; 2016; 70(4):346-52. PubMed ID: 27091891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Leachable Study of Glass Vials to Demonstrate the Impact of Low Fill Volume.
    Hladik B; Buscke F; Frost R; Rothhaar U
    PDA J Pharm Sci Technol; 2019; 73(4):345-355. PubMed ID: 30770482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new glass option for parenteral packaging.
    Schaut RA; Peanasky JS; DeMartino SE; Schiefelbein SL
    PDA J Pharm Sci Technol; 2014; 68(5):527-34. PubMed ID: 25336422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexing Agents and pH Influence on Chemical Durability of Type I Molded Glass Containers.
    Biavati A; Poncini M; Ferrarini A; Favaro N; Scarpa M; Vallotto M
    PDA J Pharm Sci Technol; 2017; 71(4):306-316. PubMed ID: 28747538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Effects of the Chemical Composition on Glass Corrosion: A Case Study for Type I Vials.
    Panighello S; Pinato O
    PDA J Pharm Sci Technol; 2020; 74(2):185-200. PubMed ID: 31615925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Patient Safety through the Use of a Pharmaceutical Glass Designed To Prevent Cracked Containers.
    Schaut RA; Hoff KC; Demartino SE; Denson WK; Verkleeren RL
    PDA J Pharm Sci Technol; 2017; 71(6):511-528. PubMed ID: 28928290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of surface properties of glass vials used as primary packaging material for parenterals.
    Ditter D; Mahler HC; Roehl H; Wahl M; Huwyler J; Nieto A; Allmendinger A
    Eur J Pharm Biopharm; 2018 Apr; 125():58-67. PubMed ID: 29331438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing the Alba® Primary Packaging Platform. Part 2: Inorganic Extractables Evaluation.
    Chillon A; Zuccato D
    PDA J Pharm Sci Technol; 2019; 73(3):235-246. PubMed ID: 30651335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Historical Review of Glasses Used for Parenteral Packaging.
    Schaut RA; Weeks WP
    PDA J Pharm Sci Technol; 2017; 71(4):279-296. PubMed ID: 28196916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum elution and precipitation in glass vials: effect of pH and buffer species.
    Ogawa T; Miyajima M; Wakiyama N; Terada K
    Drug Dev Ind Pharm; 2015 Feb; 41(2):315-21. PubMed ID: 24261406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations.
    Jiang G; Goss M; Li G; Jing W; Shen H; Fujimori K; Le L; Wong L; Wen ZQ; Nashed-Samuel Y; Riker K; Germansderfer A; Tsang P; Ricci M
    PDA J Pharm Sci Technol; 2013; 67(4):323-35. PubMed ID: 23872443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated extractable studies of borosilicate glass containers.
    Borchert SJ; Ryan MM; Davison RL; Speed W
    J Parenter Sci Technol; 1989; 43(2):67-79. PubMed ID: 2709238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulated Leaching (Migration) Study for a Model Container-Closure System Applicable to Parenteral and Ophthalmic Drug Products.
    Jenke D; Egert T; Hendricker A; Castner J; Feinberg T; Houston C; Hunt DG; Lynch M; Nicholas K; Norwood DL; Paskiet D; Ruberto M; Smith EJ; Holcomb F; Markovic I
    PDA J Pharm Sci Technol; 2017; 71(2):68-87. PubMed ID: 27974627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the structural drivers governing glass-water interactions in borosilicate based model bioactive glasses.
    Stone-Weiss N; Pierce EM; Youngman RE; Gulbiten O; Smith NJ; Du J; Goel A
    Acta Biomater; 2018 Jan; 65():436-449. PubMed ID: 29127067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flake formation and composition in soda-lime-silica and borosilicate glasses.
    Lee JE; Kim E; Hwang JB; Choi JC; Lee JK
    Heliyon; 2023 Jun; 9(6):e16333. PubMed ID: 37292333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.
    Jenke D; Carlson T
    PDA J Pharm Sci Technol; 2014; 68(5):407-55. PubMed ID: 25336416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glass on pH-dependent stability of typhoid vaccine.
    Driesens RJ
    J Clin Microbiol; 1976 Aug; 2(2):85-8. PubMed ID: 9421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
    Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
    PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CZ-resin vials for packaging protein-based parenteral formulations.
    Qadry SS; Roshdy TH; Char H; Del Terzo S; Tarantino R; Moschera J
    Int J Pharm; 2003 Feb; 252(1-2):207-12. PubMed ID: 12550796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of packaging material on the liquid stability of interferon-alpha2b.
    Ruiz L; Reyes N; Aroche K; Tolosa V; Simanca V; Rogríguez T; Hardy E
    J Pharm Pharm Sci; 2005 Aug; 8(2):207-16. PubMed ID: 16124932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.